United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 10,855 | 13,197 | -49,327 | 32,743 | 21,773 |
| Depreciation Amortization | 12,570 | 6,157 | 18,207 | 13,060 | 8,353 |
| Income taxes - deferred | 3,599 | 6,799 | -34,394 | 18,752 | 12,467 |
| Accounts receivable | -5,943 | -23,508 | -2,329 | -7,541 | -4,625 |
| Accounts payable and accrued liabilities | -10,201 | -9,798 | 18,509 | 14,113 | 12,761 |
| Other Working Capital | -14,146 | -36,000 | 17,805 | 6,359 | 16,816 |
| Other Operating Activity | 60,679 | 47,190 | -8,900 | 256 | -3,038 |
| Operating Cash Flow | $57,413 | $4,037 | $-40,429 | $77,742 | $64,507 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -116,986 | -77,733 | -314,113 | -276,628 | -210,261 |
| PPE Investments | -49,837 | -21,271 | -124,415 | -87,855 | -46,903 |
| Sale Of Investment | 114,831 | 66,170 | 266,051 | 197,356 | 149,096 |
| Other Investing Activity | -8,994 | -2,735 | -8,766 | 1,780 | 2,042 |
| Investing Cash Flow | $-60,986 | $-35,569 | $-181,243 | $-165,347 | $-106,026 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -32 | -50 |
| Common Stock Issued | 6,112 | 856 | 191,936 | 37,456 | 18,003 |
| Other Financing Activity | 1,592 | 187 | 21,090 | 19,105 | 9,720 |
| Financing Cash Flow | $7,704 | $1,043 | $213,026 | $56,529 | $27,673 |
| Exchange Rate Effect | -59 | -115 | -1,225 | -274 | -145 |
| Beginning Cash Position | 129,452 | 129,452 | 139,323 | 139,323 | 139,323 |
| End Cash Position | 133,524 | 98,848 | 129,452 | 107,973 | 125,332 |
| Net Cash Flow | $4,072 | $-30,604 | $-9,871 | $-31,350 | $-13,991 |
| Free Cash Flow | |||||
| Operating Cash Flow | 57,413 | 4,037 | -40,429 | 77,742 | 64,507 |
| Capital Expenditure | -49,837 | -21,271 | -124,415 | -87,855 | -46,903 |
| Free Cash Flow | 7,576 | -17,234 | -164,844 | -10,113 | 17,604 |